Use of miRNA as a Biomarker in Prostate Cancer and New Approaches

Abstract

Prostate cancer has been found to be the most life-threatening disease among men all over the world,given its wide occurrence and partially-successful therapies associated with a high rate of mortality.Thus, meticulous analysis of this cancer and its characteristics, including molecular biology, epigeneticmechanisms and markers during tumor development, may provide the scientists with valuable insightsto design the therapeutic protocol with improved efficiency and low rate of failure and limited furtherside effects, such as infertility. Moreover, the risk associated with the current invasive procedures onprostate cancer patients has prompted researchers to invest effort in the discovery of being less-invasiveand more advantageous procedures based on the patient’s own physiological and anatomical characteristics. This paper reviews past and present studies on epigenetics and molecular markers of prostatecancer, as well as the designed therapies. Additionally, we present a future vision and prospect of thecurrent treatments.